AU512593B2 - Sodium cromoglycate - Google Patents

Sodium cromoglycate

Info

Publication number
AU512593B2
AU512593B2 AU21626/77A AU2162677A AU512593B2 AU 512593 B2 AU512593 B2 AU 512593B2 AU 21626/77 A AU21626/77 A AU 21626/77A AU 2162677 A AU2162677 A AU 2162677A AU 512593 B2 AU512593 B2 AU 512593B2
Authority
AU
Australia
Prior art keywords
sodium cromoglycate
cromoglycate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU21626/77A
Other languages
English (en)
Other versions
AU2162677A (en
Inventor
K. Stevenson N. A. Kirk W. F. and Soules C Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU512593(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU2162677A publication Critical patent/AU2162677A/en
Application granted granted Critical
Publication of AU512593B2 publication Critical patent/AU512593B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU21626/77A 1976-01-30 1977-01-25 Sodium cromoglycate Expired AU512593B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GBGB3672-76 1976-01-30
GBGB51136-76 1976-12-03
GB5113676 1976-12-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU61696/80A Addition AU543418B2 (en) 1980-08-22 1980-08-22 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
AU2162677A AU2162677A (en) 1978-08-03
AU512593B2 true AU512593B2 (en) 1980-10-16

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21626/77A Expired AU512593B2 (en) 1976-01-30 1977-01-25 Sodium cromoglycate

Country Status (14)

Country Link
JP (1) JPS5294411A (hu)
AU (1) AU512593B2 (hu)
DE (1) DE2703119A1 (hu)
DK (2) DK154766C (hu)
ES (1) ES455478A1 (hu)
FI (1) FI770215A (hu)
FR (1) FR2339604A1 (hu)
IE (1) IE44760B1 (hu)
IL (1) IL51314A (hu)
LU (1) LU76661A1 (hu)
NL (1) NL185446C (hu)
NO (2) NO151860C (hu)
NZ (1) NZ183157A (hu)
SE (2) SE442268B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (hu) * 1987-03-05 1988-09-12
JPS63138229U (hu) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
ATE171865T1 (de) * 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
WO2000007567A1 (de) 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (hu) * 1956-03-21 1900-01-01
BE556587A (hu) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ183157A (en) 1979-08-31
DE2703119C2 (hu) 1990-10-25
JPS5294411A (en) 1977-08-09
NO151860B (no) 1985-03-11
SE442268B (sv) 1985-12-16
DK357588D0 (da) 1988-06-29
DK38077A (da) 1977-07-31
IL51314A0 (en) 1977-03-31
NO780183L (no) 1977-08-02
LU76661A1 (hu) 1977-08-03
IE44760L (en) 1977-07-30
FR2339604B1 (hu) 1980-12-05
DK156876B (da) 1989-10-16
DK357588A (da) 1988-06-29
SE7700888L (sv) 1977-07-31
FR2339604A1 (fr) 1977-08-26
SE8107278L (sv) 1981-12-04
DK154766B (da) 1988-12-19
JPS6129929B2 (hu) 1986-07-10
IE44760B1 (en) 1982-03-24
DK154766C (da) 1989-05-22
NL185446B (nl) 1989-11-16
SE442267B (sv) 1985-12-16
FI770215A (hu) 1977-07-31
AU2162677A (en) 1978-08-03
NO770286L (no) 1977-08-02
NL7700911A (nl) 1977-08-02
NL185446C (nl) 1990-04-17
NO151860C (no) 1985-06-19
DK156876C (da) 1990-03-12
DE2703119A1 (de) 1977-08-04
ES455478A1 (es) 1978-02-01
IL51314A (en) 1980-03-31

Similar Documents

Publication Publication Date Title
AU519064B2 (en) 4-n-acylfortimicin b derivatives
AU512593B2 (en) Sodium cromoglycate
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU504526B2 (en) Pipeazine derivatives
AU517829B2 (en) Morphanthridine derivatives
AU510620B2 (en) Benzodioxole derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU506483B2 (en) Thiophosphate derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU512953B2 (en) Substituted phenylguanidines
AU512647B2 (en) Solpenamide derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
SU565168A1 (ru) Микрокриогенна установка
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU540464B2 (en) Morphanthridine derivatives
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU495377B2 (en) 3-nitropyrazole derivatives